Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 6/20 | 0.50 |
| ▸ | CCNT1 | O60563 | 7/20 | 0.44 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.43 |
| ▸ | SMO | Q99835 | 3/20 | 0.40 |
| ▸ | PRKDC | P78527 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CAMK1D | Q8IU85 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CCNK | O75909 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9929727 | 0.81 | CDK9 (0.49) | CDK9CCNT1CCNK | |
| SCHEMBL27873413 | 0.80 | CDK9 (0.56) | CDK9LRRK2SMO | |
| SCHEMBL27873288 | 0.80 | CDK9 (0.56) | CDK9LRRK2SMO | |
| SCHEMBL10242056 | 0.78 | CDK9 (0.55) | CDK9CCNT1 | |
| SCHEMBL10244032 | 0.77 | CDK9 (0.50) | CDK9CCNT1 | |
| SCHEMBL10242064 | 0.77 | MAPK8 (0.51) | CDK9CCNT1 | |
| SCHEMBL10242964 | 0.77 | CDK9 (0.50) | CDK9CCNT1 | |
| SCHEMBL10242740 | 0.77 | CDK9 (0.50) | CDK9CCNT1 | |
| SCHEMBL10242891 | 0.77 | CDK9 (0.50) | CDK9CCNT1 | |
| SCHEMBL10242895 | 0.76 | CDK9 (0.54) | CDK9CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |